Sign In
Buy INCR
$1.04
+0.0100 (+0.97%)
At Close: Jun 03, 2026
InterCure Announces 2025 Results with NIS 270 Million in Revenue and Positive Operating Cash Flow
06:05pm, Thursday, 30'th Apr 2026
The Company reported over NIS 270 million in revenue, NIS 37 million in Net loss, NIS 47 million in Adjusted EBITDA and NIS 17 million in positive operating cash flow, reflecting strong resilience and
InterCure Receives Nasdaq Notification Regarding Minimum Bid Requirement
04:46pm, Tuesday, 03'rd Mar 2026
NEW YORK and HERZLIYA, Israel, March 03, 2026 (GLOBE NEWSWIRE) -- InterCure Ltd. (Nasdaq: INCR) (TASE: INCR) (“InterCure” or the “Company”) today announced that on February 25, 2026 the Compan
InterCure Announces Preliminary Estimated 2025 Revenue of NIS 265 Million, Positive Adjusted EBITDA and Cash of NIS 43 Million
07:00am, Thursday, 19'th Feb 2026
InterCure reports preliminary estimated revenue of NIS 265 million for 2025 and positive Adjusted EBITDA, marking its twelfth consecutive half-year of positive Adjusted EBITDA.
InterCure Announces Preliminary Estimated 2025 Revenue of NIS 265 Million, Positive Adjusted EBITDA and Cash¹ of NIS 43 Million
07:00am, Thursday, 19'th Feb 2026
InterCure reports preliminary estimated revenue of NIS 265 million for 2025 and positive Adjusted EBITDA2, marking its twelfth consecutive half-year of positive Adjusted EBITDA. Revenue for 2025 repre
InterCure (NASDAQ:INCR) Shares Down 6.6% – Should You Sell?
01:33am, Wednesday, 31'st Dec 2025
InterCure Ltd. (NASDAQ: INCR - Get Free Report)'s stock price fell 6.6% during trading on Tuesday. The stock traded as low as $0.9895 and last traded at $0.99. 537,181 shares traded hands during mid-d
Head to Head Comparison: InterCure (NASDAQ:INCR) and Jushi (OTCMKTS:JUSHF)
02:11am, Friday, 12'th Dec 2025
InterCure (NASDAQ: INCR - Get Free Report) and Jushi (OTCMKTS:JUSHF - Get Free Report) are both medical companies, but which is the superior stock? We will contrast the two businesses based on the str
InterCure (NASDAQ:INCR) Shares Up 0.7% – Time to Buy?
02:15am, Saturday, 22'nd Nov 2025
InterCure Ltd. (NASDAQ: INCR - Get Free Report) shares were up 0.7% during mid-day trading on Friday. The company traded as high as $1.3110 and last traded at $1.3110. Approximately 2,047 shares chang
Agreements formalize research partnership combining InterCure's global pharmaceutical platform with Cannasoul's world-class analytics and scientific innovation
InterCure Reports First Half 2025 Results with NIS 130 Million in Revenue and Positive Operating Cash Flow
09:40am, Wednesday, 08'th Oct 2025
The Company reports NIS 130 million in revenue and NIS 12 million in positive operating cash flow, demonstrating resilience and sustained profitability with its eleventh consecutive half of positive A
InterCure Reports First Half 2025 Results with NIS 130 Million in Revenue and Positive Operating Cash Flow
09:02am, Wednesday, 08'th Oct 2025
The Company reports NIS 130 million in revenue and NIS 12 million in positive operating cash flow, demonstrating resilience and sustained profitability with its eleventh consecutive half of positive A
InterCure Announces Strategic Acquisition of ISHI, Unlocking Access to Premium U.S. Cannabis Technology and Brands
08:48am, Friday, 19'th Sep 2025
Acquisition of leading cannabis company marks major milestone in InterCure's commercial expansion strategy, bringing access to premium American brands and state-of-the-art cultivation technologies
2024 results were affected by damages to our southern facility caused by the terrorist attack on October 7, 2023, and the continued war in Gaza. InterCure is entitled to full compensation from the I
InterCure Names Alexander Rabinovich as Chairman Replacing Ehud Barak
06:35pm, Wednesday, 12'th Feb 2025
NEW YORK and HERZLIYA, Israel , Feb. 12, 2025 /PRNewswire/ -- InterCure Ltd. (NASDAQ: INCR) (TASE: INCR) (dba Canndoc) ("InterCure" or the "Company"), announces today that Mr.
InterCure has Secured Funding of NIS 66M to support the recovery of Nir Oz Facility
08:32am, Friday, 20'th Dec 2024
The funding may increase to NIS 107M to support the expansion of the facility in collaboration with the "Tkumah" administration, post-war. The funding includes investments from key shareholders of the
Are Investors Missing The Forest? 35% Stock Drop Masks The International Potential Of This Weed Company
02:32pm, Saturday, 14'th Sep 2024
InterCure Ltd. INCR has shown resilience in its H1 2024 performance despite facing significant challenges, according to equity research by Pablo Zuanic of Zuanic & Associates.
